Episode 2206
2206: Interview with CEO, Sara Barrington of Verici DX
The Vox Markets Podcast · Vox Markets Podcast
October 8, 202526m 22s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this upbeat interview, CEO Sara Barrington of Verici DX – a next generation medical diagnostics firm focusing on the global kidney transplant market - takes me through:
00:00 Progress on #VRCI’s commercialisation strategy following July’s £6.35m fund raise and Monday’s in line H1’25 results.
11:20 Future Tutivia volumes and #VRCI breakeven sales level
14:50 Update on Thermo Fisher Scientific relationship (re pre-graft Clarava/PTRA test)
19:15 Other products/services and closing remarks
00:00 Progress on #VRCI’s commercialisation strategy following July’s £6.35m fund raise and Monday’s in line H1’25 results.
11:20 Future Tutivia volumes and #VRCI breakeven sales level
14:50 Update on Thermo Fisher Scientific relationship (re pre-graft Clarava/PTRA test)
19:15 Other products/services and closing remarks